FEED logo

ENVUE MEDICAL INC

FEEDNASDAQ
🏆 #5435 by market capEarnings Nov 17US Equity
$951.08▲ $31.10 (+3.27%)
Simulated price
🔔
Track FEED
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.3%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$797,964
Small Cap
📈Revenue Growth (YoY)
-0.2%
Declining
📊Gross Margin
-26.1%
Thin
💵FCF Margin
-609.8%
Thin
⚖️P/S Ratio
0.4x
Cheap
Otter Score
44
Weak
No chart data available for FEED.

Trading Snapshot

Day Range
$939.44 – $963.07
52-Week Range
$0.29 – $5.98
Volume
$2.64B
Avg Volume
$2.53B
Shares Outstanding
774,722
Next Earnings
Oct 29, 2026

Fundamentals Snapshot

Annual Revenue
$3M
Last Q Revenue
$239,000
P/E Ratio
-0.0
P/S Ratio
0.4x
EPS (TTM)
$-40.87
Dividend Yield
0.00%
Dilution (1yr)
+2605.6%

Why Investors Own FEED

  • ✓High-growth profile — revenue up +14.3% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 47% gross margin and 18% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

FEED logo

ENVUE MEDICAL INC

FEED
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3M▼ −0.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
6.0%▼ −89.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$12M▲ +227.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$9M▲ +274.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
72K▲ +2605.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▲ +$2M YoY
StockOtter · stockotter.space

About ENVUE MEDICAL INC

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
44/100

Analyst Price Target

ⓘ
Average Target
$1,187.65
▲ +24.9% Upside
High Target$1,353.73
Low Target$1,058.14
Based on 38 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

ENVUE MEDICAL INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift FEED price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
CNBC·1d ago

ENVUE MEDICAL INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.